scholarly article | Q13442814 |
P50 | author | Gerd Geerling | Q15280969 |
P2093 | author name string | Gary N Foulks | |
Michael A Lemp | |||
Kelly K Nichols | |||
Benjamin D Sullivan | |||
Francisco Figueiredo | |||
Elisabeth M Messmer | |||
Philipp Baenninger | |||
Leslie A Crews | |||
P2860 | cites work | The "independent components" of natural scenes are edge filters | Q24597136 |
Concordance between common dry eye diagnostic tests | Q34412458 | ||
Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. | Q34620626 | ||
Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency | Q35591872 | ||
Minimal clinically important difference for the ocular surface disease index | Q37672025 | ||
Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain | Q40026647 | ||
Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca | Q41786016 | ||
Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome | Q42940964 | ||
A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes | Q44113281 | ||
The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity | Q44631963 | ||
The lack of association between signs and symptoms in patients with dry eye disease | Q45122466 | ||
A link between tear instability and hyperosmolarity in dry eye. | Q46072952 | ||
The Effect of instilled fluorescein solution volume on the values and repeatability of TBUT measurements. | Q46701328 | ||
Clinical impact of conjunctivochalasis on the ocular surface | Q46755643 | ||
An objective approach to dry eye disease severity | Q48343172 | ||
A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. | Q48613858 | ||
Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. | Q50548182 | ||
Factors Affecting Tear Film Breakup in Normal Eyes | Q52731414 | ||
Survey of preferred tests for diagnosis of the tear film and dry eye. | Q54135549 | ||
Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
P433 | issue | 2 | |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 161-166 | |
P577 | publication date | 2012-12-28 | |
P1433 | published in | Acta Ophthalmologica | Q15716498 |
P1476 | title | Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications | |
P478 | volume | 92 |
Q37676992 | A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye. |
Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
Q34364536 | A review of quality of life measures in dry eye questionnaires |
Q35988343 | Accuracy of McMonnies Questionnaire as a Screening Tool for Chinese Ophthalmic Outpatients |
Q89536714 | An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease |
Q89539996 | Aqueous deficiency is a contributor to evaporation-related dry eye disease |
Q92799224 | Assessment of tear film in subjects with a high body mass index |
Q60919214 | Assessment of tear-evaporation rate in thyroid-gland patients |
Q50201362 | Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. |
Q33713187 | Association of dry eye disease with psychiatric or neurological disorders in elderly patients |
Q26781979 | Associations between signs and symptoms of dry eye disease: a systematic review |
Q89172342 | Changes in ocular surface status after phacoemulsification in patients with senile cataract |
Q39960842 | Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms. |
Q90708409 | Choosing Core Outcomes for Use in Clinical Trials in Ophthalmology: Perspectives from Three Ophthalmology Outcomes Working Groups |
Q37067291 | Chronic dry eye disease is principally mediated by effector memory Th17 cells |
Q39151688 | Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature |
Q60922643 | Clinically Relevant Immune-Cellular Metrics of Inflammation in Meibomian Gland Dysfunction |
Q35798154 | Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye |
Q33645315 | Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease |
Q95729513 | Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study |
Q36898549 | Corneal permeability changes in dry eye disease: an observational study |
Q37536295 | Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). |
Q34144866 | Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population based analysis |
Q36009304 | Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility. |
Q90319698 | Dry Eye Indexes Estimated by Keratograph 5M of Systemic Lupus Erythematosus Patients without Secondary Sjögren's Syndrome Correlate with Lupus Activity |
Q39404635 | Dry Eye Management: Targeting the Ocular Surface Microenvironment. |
Q47583935 | Dry Eye Symptoms, Patient-Reported Visual Functioning, and Health Anxiety Influencing Patient Satisfaction After Cataract Surgery |
Q98611558 | Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker |
Q48048316 | Dry eye symptoms align more closely to non-ocular conditions than to tear film parameters |
Q93017935 | Dysfunctional Coping Mechanisms Contribute to Dry Eye Symptoms |
Q26770830 | Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review |
Q37250982 | Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity |
Q41560816 | Effect of hyaluronic acid on tear film thickness as assessed with ultra-high resolution optical coherence tomography |
Q60307243 | Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study |
Q37600492 | Estimating the Osmolarities of Tears During Evaporation Through the "Eyes" of the Corneal Nerves |
Q39816145 | Evaluating the Functionality of Conjunctiva Using a Rabbit Dry Eye Model. |
Q37717435 | Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure |
Q37444735 | Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose |
Q39829599 | Evidence of seasonality and effects of psychrometry in dry eye disease |
Q38905054 | External eye symptoms in indoor environments |
Q55174890 | Factors associated with severe dry eye in primary Sjögren's syndrome diagnosed patients. |
Q26778628 | Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis |
Q90223560 | Impact of Dry Eye Disease on Vision Quality: An Optical Quality Analysis System Study |
Q33621122 | Impression cytology implicates cell autophagy in aqueous deficiency dry eye. |
Q92669446 | Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up |
Q35843885 | In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye Patients |
Q26771221 | In pursuit of objective dry eye screening clinical techniques |
Q35970028 | In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study. |
Q60047806 | Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests |
Q53534950 | Keratitis in Dry Eye Disease and Topical Ciclosporin A. |
Q47936168 | Mechanisms, imaging and structure of tear film breakup |
Q41493127 | Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome |
Q43075719 | Neuropathic Corneal Pain: Approaches for Management |
Q38840388 | New Treatment Guidelines for Sjögren's Disease |
Q48145043 | Ocular Demodex folliculorum: prevalence and associated symptoms in an Irish population |
Q92310446 | Ocular Surface Changes in Prostaglandin Analogue-Treated Patients |
Q53458807 | Orbital lobe resection provides a definite diagnosis of lacrimal gland lesions: a report of three cases. |
Q35122497 | Past and present of corneal refractive surgery: a retrospective study of long-term results after photorefractive keratectomy and a prospective study of refractive lenticule extraction |
Q37390513 | Photorefractive keratectomy for patients with preoperative low Schirmer test value |
Q89867666 | Prevalence of Signs and Symptoms of Dry Eye Disease 5 to 15 After Refractive Surgery |
Q99411668 | Prevalence of dry eye disease in the elderly: A protocol of systematic review and meta-analysis |
Q28073073 | Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis |
Q54956654 | Prevention, diagnosis & management of dry eye in South Asia. |
Q54943596 | Proinflammatory Markers, Chemokines, and Enkephalin in Patients Suffering from Dry Eye Disease. |
Q58781979 | Quality of life measures and health utility values among dry eye subgroups |
Q37046020 | Relationships among Tear Film Stability, Osmolarity, and Dryness Symptoms |
Q57169068 | Research Questions and Outcomes Prioritized by Patients With Dry Eye |
Q92873483 | Response to "Variability of Tear Osmolarity Measurements With a Point-of-Care System in Healthy Subjects-Systematic Review" |
Q98564807 | Seasonal variation of intra-ocular pressure in glaucoma with and without dry eye |
Q40953641 | Self versus examiner administration of the Ocular Surface Disease Index© |
Q35472653 | Sensitization of trigeminal brainstem pathways in a model for tear deficient dry eye |
Q34781707 | Subbasal nerve morphology, corneal sensation, and tear film evaluation after refractive femtosecond laser lenticule extraction |
Q38652990 | TFOS DEWS II Tear Film Report. |
Q39453338 | TFOS DEWS II pain and sensation report. |
Q90481097 | TRPV1 and TRPM8 Channels and Nocifensive Behavior in a Rat Model for Dry Eye |
Q36257052 | Tear film osmolarity and dry eye disease: a review of the literature |
Q36039088 | The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye |
Q41405231 | The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye. |
Q47611773 | The Role of Health Anxiety and Depressive Symptoms in Dry Eye Disease |
Q39233384 | The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board |
Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
Q88362505 | The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population |
Q48265701 | Trigeminal brainstem modulation of persistent orbicularis oculi muscle activity in a rat model of dry eye. |
Q90403120 | Update on the role of impression cytology in ocular surface disease |
Q90696025 | Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease |
Q37397203 | What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? |
Search more.